Anjan Drug Profile
Key Indicators
- Authorised Capital ₹ 26.10 Cr
- Paid Up Capital ₹ 6.00 Cr
- Company Age 34 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 92.90 Cr
- Satisfied Charges ₹ 295.76 Cr
- Revenue Growth 60.61%
- Profit Growth 123.00%
- Ebitda 112.52%
- Net Worth 35.42%
- Total Assets 26.95%
About Anjan Drug
Anjan Drug Private Limited (ADPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 August 1990 and has a history of 34 years and six months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Corporate was formerly known as Anjan Drugs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 26.10 Cr and a paid-up capital of Rs 6.00 Cr.
The company currently has active open charges totaling ₹92.90 Cr. The company has closed loans amounting to ₹295.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Anjan Drug Private Limited India is Archana Jalla as COMPANY SECRETARY. Vivek Chhachhi, Chinnannan Kalaichelvan, Anil Khubchandani, and One other member serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TN1990PTC019461
-
Company No.
019461
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Aug 1990
-
Date of AGM
12 Oct 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Anjan Drug?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Archana Jalla
|
Company Secretary | 01-Jul-2014 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Vivek Chhachhi
|
Nominee Director | 09-Oct-2020 | Current |
|
Chinnannan Kalaichelvan
|
Director | 01-Aug-1990 | Current |
|
Anil Khubchandani
|
Director | 27-Jun-2023 | Current |
| Pagadala Baskarannarayanan | Director | 11-Jan-2023 | Current |
Financial Performance of Anjan Drug.
Anjan Drug Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60.61% increase. The company also saw a substantial improvement in profitability, with a 123% increase in profit. The company's net worth Soared by an impressive increase of 35.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anjan Drug?
In 2023, Anjan Drug had a promoter holding of 30.00% and a public holding of 70.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Optimus Life Science Private LimitedAnil Khubchandani and Pagadala Baskarannarayanan are mutual person
-
Optimus Drugs Private Limited
Anil Khubchandani and Pagadala Baskarannarayanan are mutual person
-
Optimus Pharma Private Limited
Anil Khubchandani and Pagadala Baskarannarayanan are mutual person
-
Sabine Hospital & Research Centre Private LimitedVivek Chhachhi is a mutual person
-
Veeda Clinical Research LimitedVivek Chhachhi is a mutual person
-
Jubilant Ingrevia LimitedAnil Khubchandani is a mutual person
Charges (Loans)
₹92.90 Cr
₹295.76 Cr
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 31.70 Cr
- Hdfc Bank Limited : 31.20 Cr
- Others : 30.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Mar 2022 | Others | ₹15.00 Cr | Open |
| 21 Oct 2021 | Hdfc Bank Limited | ₹31.20 Cr | Open |
| 01 Jun 2021 | Others | ₹15.00 Cr | Open |
| 22 Apr 2021 | Axis Bank Limited | ₹31.70 Cr | Open |
| 09 Jun 2022 | Hdfc Bank Limited | ₹14.50 Cr | Satisfied |
How Many Employees Work at Anjan Drug?
Anjan Drug has a workforce of 297 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anjan Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anjan Drug's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
